CIK 0001062822
- Non-accelerated filer
- Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760474169
- Phone
- +1 281-863-3000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-04-24 | Swain Judith L Director | Grant or award · Restricted Stock Units | +10,638 | 10,638 | ||
| 2020-04-24 | SOBECKI CHRISTOPHER J Director | Grant or award · Stock Option (Right to Buy) | +18,115 | 18,115 | ||
| 2020-04-24 | SOBECKI CHRISTOPHER J Director | Grant or award · Restricted Stock Units | +10,638 | 10,638 | ||
| 2020-04-24 | Palantoni Frank Director | Grant or award · Stock Option (Right to Buy) | +18,115 | 18,115 | ||
| 2020-04-24 | Palantoni Frank Director | Grant or award · Restricted Stock Units | +10,638 | 10,638 | ||
| 2020-04-24 | NIES ALAN S Director | Grant or award · Stock Option (Right to Buy) | +18,115 | 18,115 | ||
| 2020-04-24 | NIES ALAN S Director | Grant or award · Restricted Stock Units | +10,638 | 10,638 | ||
| 2020-04-24 | LEFKOWITZ ROBERT J MD Director | Grant or award · Stock Option (Right to Buy) | +18,115 | 18,115 | ||
| 2020-04-24 | LEFKOWITZ ROBERT J MD Director | Grant or award · Restricted Stock Units | +10,638 | 10,638 | ||
| 2020-04-24 | DEBBANE RAYMOND Director | Grant or award · Stock Option (Right to Buy) | +18,115 | 18,115 | ||
| 2020-04-24 | DEBBANE RAYMOND Director | Grant or award · Restricted Stock Units | +10,638 | 10,638 | ||
| 2020-04-24 | BARKER SAM L Director | Grant or award · Stock Option (Right to Buy) | +18,115 | 18,115 | ||
| 2020-04-24 | BARKER SAM L Director | Grant or award · Restricted Stock Units | +10,638 | 10,638 | ||
| 2020-04-24 | Amouyal Philippe Director | Grant or award · Stock Option (Right to Buy) | +18,115 | 18,115 | ||
| 2020-04-24 | Amouyal Philippe Director | Grant or award · Restricted Stock Units | +10,638 | 10,638 | ||
| 2020-04-22 | WADE JEFFREY L EVP, Corp Adm Affairs and CFO | Grant or award | +26,525 | 125,146 | ||
| 2020-04-22 | WADE JEFFREY L EVP, Corp Adm Affairs and CFO | Shares withheld for taxes | −9,651 | $1.96 | $19K | 115,495 |
| 2020-04-22 | TYLE PRAVEEN EVP, R&D | Grant or award | +19,893 | 74,188 | ||
| 2020-04-22 | TYLE PRAVEEN EVP, R&D | Shares withheld for taxes | −4,844 | $1.96 | $9K | 69,344 |
| 2020-04-22 | Tessmer James F VP, Finance & Accounting | Grant or award | +13,262 | 69,124 |
Page 33 of 51 · 1,001 trades